<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Magn Reson Insights</journal-id><journal-id journal-id-type="iso-abbrev">Magn Reson Insights</journal-id><journal-id journal-id-type="publisher-id">Magnetic Resonance Insights</journal-id><journal-title-group><journal-title>Magnetic Resonance Insights</journal-title></journal-title-group><issn pub-type="epub">1178-623X</issn><publisher><publisher-name>Libertas Academica</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26279622</article-id><article-id pub-id-type="pmc">4512634</article-id><article-id pub-id-type="doi">10.4137/MRI.S30060</article-id><article-id pub-id-type="publisher-id">mri-8-2015-023</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction to &#x0201c;Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study&#x0201d;</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gutierrez</surname><given-names>Juan E</given-names></name><xref ref-type="aff" rid="af1-mri-8-2015-023">1</xref><xref ref-type="corresp" rid="c1-mri-8-2015-023"/></contrib><contrib contrib-type="author"><name><surname>Rosenberg</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="af2-mri-8-2015-023">2</xref></contrib><contrib contrib-type="author"><name><surname>Seemann</surname><given-names>J&#x000f6;rg</given-names></name><xref ref-type="aff" rid="af3-mri-8-2015-023">3</xref></contrib><contrib contrib-type="author"><name><surname>Breuer</surname><given-names>Josy</given-names></name><xref ref-type="aff" rid="af4-mri-8-2015-023">4</xref></contrib><contrib contrib-type="author"><name><surname>Haverstock</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="af2-mri-8-2015-023">2</xref></contrib><contrib contrib-type="author"><name><surname>Agris</surname><given-names>Jacob</given-names></name><xref ref-type="aff" rid="af2-mri-8-2015-023">2</xref></contrib><contrib contrib-type="author"><name><surname>Balzer</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="af2-mri-8-2015-023">2</xref></contrib><contrib contrib-type="author"><name><surname>Anzalone</surname><given-names>Nicoletta</given-names></name><xref ref-type="aff" rid="af5-mri-8-2015-023">5</xref></contrib></contrib-group><aff id="af1-mri-8-2015-023"><label>1</label>Neuroradiology Section, The University of Texas Health Science Center at San Antonio, TX, USA.</aff><aff id="af2-mri-8-2015-023"><label>2</label>Bayer Healthcare Pharmaceuticals, Montville, NJ, USA.</aff><aff id="af3-mri-8-2015-023"><label>3</label>Department of Neuroradiology, Werner-For&#x000df;mann Krankenhaus, Eberswalde, Germany.</aff><aff id="af4-mri-8-2015-023"><label>4</label>Global Clinical Imaging Services, Bayer Pharma AG, Berlin, Germany.</aff><aff id="af5-mri-8-2015-023"><label>5</label>Neuroradiology Department, Scientific Institute HSR Raffaele, Milan, Italy.</aff><author-notes><corresp id="c1-mri-8-2015-023">CORRESPONDENCE: <email>juanes65@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>21</day><month>7</month><year>2015</year></pub-date><volume>8</volume><fpage>23</fpage><lpage>23</lpage><permissions><copyright-statement>&#x000a9; 2015 the author(s), publisher and licensee Libertas Academica Ltd.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access"><license-p>This is an open-access article distributed under the terms of the Creative Commons CC-BY-NC 3.0 License.</license-p></license></permissions></article-meta></front><body><p>The authors of Gutierrez JE, Rosenberg M, Seemann J, et&#x000a0;al. Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study. <italic>Magnetic Resonance Insights.</italic> 2015;8:<related-article related-article-type="corrected-article" id="d35e147" vol="8" page="1" ext-link-type="pmc">1&#x02013;10</related-article>. doi:10.4137/MRI.S19794 wish to advise that there was an error in the text on page 6 of the paper, in the sentences describing Figure 5. This text should have read as follows:</p><p>Figure 5 shows a patient with <bold>brain metastasis from lung cancer</bold>. The gadobutrol-enhanced T1w image (a) shows a small foci of increased signal intensity near the gray-white interphase in the left temporal lobe, which was interpreted as a metastatic tumor/carcinomatosis by the blinded readers (all three readers) (Fig. 5A), whereas the gadoteridol-enhanced T1w image (b) had no identifiable foci and only a vague increase in signal intensity on this image and no increased signal intensity on the adjoining slices so the blinded readers did not diagnose a metastatic tumor nor carcinomatosis in the left temporal lobe (zero of three readers) when viewing the combined contrast-enhanced and pre-contrast images (Fig. 5B).</p><p>The editor in chief thanks the authors for drawing their error to readers&#x02019; attention.</p></body><back><fn-group><fn id="fn1-mri-8-2015-023"><p><bold>ACADEMIC EDITOR:</bold> Sendhil Velan, Editor in Chief</p></fn></fn-group></back></article>